These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9669188)

  • 1. Postexcitatory inhibition after transcranial magnetic stimulation of the motor cortex in patients with drug-induced parkinsonism and in healthy individuals.
    Masur H; Althoff S; Erim Y; Oberwittler C; Hornung WP
    Int Clin Psychopharmacol; 1998 Mar; 13(2):79-82. PubMed ID: 9669188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
    Yamasue H; Fukui T; Fukuda R; Kasai K; Iwanami A; Kato N; Kato T
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):353-60. PubMed ID: 14604450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism.
    Priori A; Berardelli A; Inghilleri M; Accornero N; Manfredi M
    Brain; 1994 Apr; 117 ( Pt 2)():317-23. PubMed ID: 8186958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Instrumental motor predictors of neuroleptic-induced parkinsonism in newly medicated schizophrenia patients.
    Caligiuri MP; Lohr JB
    J Neuropsychiatry Clin Neurosci; 1997; 9(4):562-7. PubMed ID: 9447497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study.
    Avorn J; Bohn RL; Mogun H; Gurwitz JH; Monane M; Everitt D; Walker A
    Am J Med; 1995 Jul; 99(1):48-54. PubMed ID: 7598142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism.
    Morley JF; Pawlowski SM; Kesari A; Maina I; Pantelyat A; Duda JE
    Parkinsonism Relat Disord; 2014 Jul; 20(7):738-42. PubMed ID: 24742370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.
    Munhoz RP; Bertucci Filho D; Teive HA
    Neurol Sci; 2017 Feb; 38(2):319-324. PubMed ID: 27853909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetry in clinical features of drug-induced parkinsonism.
    Sethi KD; Zamrini EY
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):64-6. PubMed ID: 1983774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of extrapyramidal symptoms to age at onset and drug treatment in middle-aged and elderly schizophrenic patients.
    Srinivasan TN; Thara R; Padmavathi R; McCreadie RG
    Schizophr Res; 2001 Jan; 47(1):69-75. PubMed ID: 11163546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validating the Simpson-Angus Extrapyramidal Collateral Symptom Evaluation Scale].
    Calvo-Gómez JM; Sánchez-Pedraza R; Jaramillo-González LE; Tarcisio-Mantilla C
    Rev Salud Publica (Bogota); 2006; 8(1):74-87. PubMed ID: 16703964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of simultaneous movements distinguishes depressive motor retardation from Parkinson's disease and neuroleptic parkinsonism.
    Fleminger S
    Brain; 1992 Oct; 115 ( Pt 5)():1459-80. PubMed ID: 1358398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapyramidal side effects: a historical perspective.
    Rifkin A
    J Clin Psychiatry; 1987 Sep; 48 Suppl():3-6. PubMed ID: 2887555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) as a subjective measure of drug-induced parkinsonism and akathisia.
    Jung HY; Kim JH; Ahn YM; Kim SC; Hwang SS; Kim YS
    Hum Psychopharmacol; 2005 Jan; 20(1):41-5. PubMed ID: 15565639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs.
    Marsden CD; Jenner P
    Psychol Med; 1980 Feb; 10(1):55-72. PubMed ID: 6104342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrapyramidal side effects in patients with Alzheimer's disease treated with low-dose neuroleptic medication.
    Caligiuri MP; Rockwell E; Jeste DV
    Am J Geriatr Psychiatry; 1998; 6(1):75-82. PubMed ID: 9469217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroconvulsive therapy in neuroleptic-induced parkinsonism.
    Goswami U; Dutta S; Kuruvilla K; Papp E; Perenyi A
    Biol Psychiatry; 1989 Jul; 26(3):234-8. PubMed ID: 2568133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute neuroleptic-induced movement disorders.
    Tonda ME; Guthrie SK
    Pharmacotherapy; 1994; 14(5):543-60. PubMed ID: 7997388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characteristics of subjective akathisia, objective akathisia, and mixed akathisia in chronic schizophrenic subjects.
    Kim JH; Byun HJ
    Clin Neuropharmacol; 2003; 26(6):312-6. PubMed ID: 14646611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Painful sensory symptoms in neuroleptic-induced extrapyramidal syndromes.
    Decina P; Mukherjee S; Caracci G; Harrison K
    Am J Psychiatry; 1992 Aug; 149(8):1075-80. PubMed ID: 1353315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.